ArticlePain research & management2019
Personality and Personality Disorders in Medication-Overuse Headache: A Controlled Study by SWAP-200.
Article in Pain research & management, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06138171 (Psychological Layers of Nociplastic Pain), which is not on this map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Psychological Layers of Nociplastic Pain: Cluster Analysis of The Role of Personality Traits, Defence Mechanisms, Central Sensitization, and Childhood Traumatic Experiences in Patients With Chronic Migraine, Fibromyalgia, and Vulvodynia
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Eating disorders and disordered eating symptoms in individuals at clinical high risk for psychosis: a systematic review and meta-analysis.Eating and weight disorders : EWD · 2024Pooled it
- Personality Factors in Colorectal Cancer: A Systematic Review.Frontiers in psychology · 2021Pooled it
- Applying the Defense Mechanisms Rating Scales Q-sort to assess patients' level of overall defensive functioning in interview data: validity and reliability.Research in psychotherapy (Milano) · 2025Article
- Loneliness and Social Isolation in Individuals with Acute Myocardial Infarction and Takotsubo Syndrome: A Scoping Review.Healthcare (Basel, Switzerland) · 2025Review
- Defense mechanisms in immune-mediated diseases: a cross-sectional study focusing on Severe Allergic Asthma and Hymenoptera Venom Anaphylaxis patients.Frontiers in psychology · 2025Article
- Therapists' defense use impacts their patients' defensive functioning: a systematic case study.Research in psychotherapy (Milano) · 2024Article
- Theory of mind in chronic migraine with medication overuse assessed with the MASC.Scientific reports · 2024Article
- Defense mechanisms in individuals with depressive and anxiety symptoms: a network analysis.Frontiers in psychology · 2024Article
- Psychological impairment in inflammatory bowel diseases: the key role of coping and defense mechanisms.Research in psychotherapy (Milano) · 2023Article
- A Descriptive Review of Medication-Overuse Headache: From Pathophysiology to the Comorbidities.Brain sciences · 2023Review
- Social cognition in chronic migraine with medication overuse: a cross-sectional study on different aspects of mentalization and social relationships.The journal of headache and pain · 2023Article
- Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study.The journal of headache and pain · 2021Article
- The Ruminative Thought Style with Associated Anxiety Influences the Occurrence of Medication-Overuse Headache.Journal of clinical neurology (Seoul, Korea) · 2021Article
- Editorial: Personality and Disease: New Directions in Modern Research.Frontiers in psychology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Medication-overuse headache (MOH) is a type of chronic headache, whose mechanisms are still unknown. The impact of psychological factors has been matter of debate from different perspectives. The role of personality and personality pathology in processes involved in MOH development has been advanced but was poorly studied. The hypothesis of addiction-like behaviors sustaining the drug misuse has been examined and reached contrasting findings. Objectives: This study is aimed at detecting personality and its disorders (PDs) in MOH, with a specific attention to the addiction aspect. Methods: Eighty-eight MOH patients have been compared with two clinical populations including 99 patients with substance use disorder (SUD) and 91 with PDs using the Shedler-Westen Assessment Procedure-200 (SWAP-200), a clinician-report tool that assesses both normal and pathological personality. MANCOVAs were performed to evaluate personality differences among MOH, SUD, and PD groups, controlling for age and gender. Results: MOH patients were predominantly women and older. They showed lower traits of the SWAP-200's cluster A and B disorders than SUD and PD patients, who presented more severe levels of personality impairment. No differences in the SWAP-200's cluster C have been found, indicating common personality features in these populations. At levels of specific PDs, MOH patients showed higher obsessive and dysphoric traits and better overall psychological functioning than SUD and PD patients. Conclusion: Although MOH, SUD, and PD populations have been evaluated in multiple sites with different levels of expertise, the study supported the presence of a specific constellation of personality in MOH patients including obsessive (perfectionist) and dysphoric characteristics, as well as good enough psychological resources. No similarities to drug-addicted and personality-disordered patients were found. Practitioners' careful understanding of the personality characteristics of MOH patients may be useful to provide a road map for the implementation of more effective treatment strategies and intervention programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.